Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-24T10:01:35.669Z Has data issue: false hasContentIssue false
  • English
  • Français

Erblichkeitsprobleme bei der Blutkoagulierung

Published online by Cambridge University Press:  01 August 2014

Wolfgang Lehmann
Wolfgang Lehmann*
Affiliation:
Kiel

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The Author reports on genetic problems of blood coagulation. Recent haematological reports on haemophilia, as for instance the differentiation of haemophilia into two different types (haemophilia A and B) bring up the question of the interrelations lig between the two genes responsible for the two types. The problem of recognizing female carriers is mentioned as well as the question of existence of female hemoghilian. It is pointed to further recent haemorrhagic diathese of genetic importance, PTA deficiency as well as the Hageman factor deficiency. Comprehensive investigations of factor VII deficiency on families, in Switzerland are of special genetic interest. These investigations have shown, that in those families, patients with complete deficiency of these factors are found, as well as members of the family not showing any haemorrhagic tendency being in complete health, but a quantitative deficiency of factor VII or Stuart-Power factor can be proved. A third group of members of these families is known to be healthy, showing a normal level of these coagulation factors. Healthy persons with a certain deficiency of factor VII or Stuart-Power factor can be regarded as heterozygotes.

Sommario

SOMMARIO

Si parla di problemi genetici connessi con la coagulazione del sangue. Recenti reperti ematologici relativi all'emofilia, come p. es. la differenziazione dell'emofilia in due forme (emofilia A e B), sollevano la questione della posizione dei geni, in relazione gli uni agli altri, che stanno alla base di queste due forme. Si entra anche in merito al problema del riconoscimento delle conduttrici nonchè a quello dell'esistenza di genuini soggetti emofiliaci femminili. Si accenna pure a ulteriori, recenti diatesi emorragiche geneticamente importanti, come la mancanza di PTA e del fattore Hageman. Di particolare interesse bio-ereditario sono vaste ricerche condotte nella Svizzera su famiglie con mancanza del fattore VII ovvero del fattore Stuart-Prower. Queste ricerche hanno mostrato che in tali famiglie, accanto a malati con una mancanza quasi completa di questi fattori, ci sono anche membri di tali famiglie che non mostrano alcuna predisposizione all'emorragia e sono perfettamente sani, ma in cui tuttavia si può dimostrare, quantitativamente, una certa mancanza del fattore VII ovvero del fattore Stuart-Prower. Un terzo gruppo di membri di tali famiglie, poi, sono sani e hanno un normale contenuto di questi fattori coagulanti. Le persone sane con una certa diminuzione del fattore VII ovvero del fattore Stuart-Prower possono essere considerate quali eterozigoti.

Résumé

RÉSUMÉ

On étudie des problèmes génétiques survenant à l'occasion de la coagulation du sang. De récentes constatations ayant trait à l'hémophilie comme par exemple la différentiation de l'hémiophilie en deux formes (hémophilie A et B) soulèvent la question de la relation des gènes qui sont à la base de ces deux formes. Le problème de déceler des conductrices aussi bien que la question de l'existence de vraies hémophilies féminines sont discutés. On fait également allusion à d'autres récentes diathèses hémorragiques qui sont importantes du point de vue génétique comme la déficience de PTA et du facteur Hageman. D'un intérêt spécialement bio-héréditaire sont d'amples examens en Suisse dans des familles où une déficience du facteur VII respectivement du facteur Stuart-Prower est observée. Les examens dans ces familles ont révélé d'une part des membres malades qui font presque absolument défaut de ces facteurs mais d'autre part des membres qui ne montrent aucune prédisposition aux hémorragies étant complètement sains mais qui révèlent une certaine diminuation quantitative du facteur VII respectivement du facteur Stuart-Prower. Un troisième groupe est sain et dispose d'une teneur normale de ces facteurs coagulants. Les personnes saines qui montrent une certaine diminution du facteur VII respectivement du facteur Stuart-Prower peuvent être considérées comme des personnes hétérozygotes.

Type
Research Article
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 8 , supplement S2 , January 1959 , pp. 26 - 37
Copyright
Copyright © The International Society for Twin Studies 1959

References

Literatur

1. Aggeler, P. M., White, S.G., Glendening, M. B., Page, E. W., Leake, T. B. and Baters, G.: Plasma Thromboplastin Component (PTC) Deficiency. A new disease resembling hemophilia. Proc. Soc. Exper. Biol. a. Med., 76, 692 (1952).CrossRefGoogle Scholar
2. Andreassen, M.: Haemophili i Danmark. Opera ex Domo Biol. Hered. Hum. Univ. Hafhiensis 6, Kopenhagen (1943).Google Scholar
3. Bauer, K. H. und Wehefritz, E.: Gibt es eine Hämophilie beim Weibe. Arch. Gynäk. 121, 462 (1924).CrossRefGoogle Scholar
4. Biggs, R., Douglas, A. S., Magfarlane, R. G., Dacie, J. N., Pitney, W. R., Merskey, C. and O'Brien, J. R.: Christmas Disease. Brit. Med. J. II, 1378 (1952).CrossRefGoogle Scholar
5. Brinkhous, K. M.: Canine hemophilia. Studies on the inheritance of the disease and the clotting defect. 3rd Internat. Congr. Hematol., Cambridge 1950, S. 439.Google Scholar
6. Brinkhous, K. M. and Graham, J. B.: Hemophilia in a female dog. Science (Lancaster, Pa.), 111, 723 (1950).CrossRefGoogle Scholar
7. Brinkhous, K. M., Langdell, R. D., Penick, G. D. and Graham, J. B.: Newer approaches to the study of Hemophilia and hemophiloid states. J. Amer. Med. Assoc., 154, 481 (1954).CrossRefGoogle Scholar
8. Brinkhous, K. M. and Graham, J. B.: Hemophilia and the hemophiloid states. Symposium: What is. Hemophilia? Blood, 9, 254 (1954).CrossRefGoogle Scholar
9. Deutsch, E.: Die hämophilie-ähnlichen hämorrhagischen Diathesen. Ergebn. inn. Med. u. Kinderheilkunde. N. F. 5. 553 (1954).Google Scholar
10. Ferlin, A.: Der Wert des Prothrombinkonsumptionstestes für die Erkennung von Hämophilie und Konduktorinnen. Helvet. Chir. Acta, 18, 374 (1951).Google Scholar
11. Fischer, J., Landeeck, G. und Lenz, W.: Vergleichende Bestimmungen des antihämophilen Globulins bei beiden Geschlechtern. Klin. Wschr., 36, 20 (1958).CrossRefGoogle Scholar
12. Frick, P. G.: The relative incidence of antihemophilic Globulin, plasma thromboplastin antecedent deficiency. A study of fifty-five cases J. Labor a. Clin. Med., 43, 864 (1954).Google ScholarPubMed
13. Harris, H.: Genetical Aspects of the haemorrhagic diatheses. V. Kongress d. Europ. Ges. f. Hämatologie. Herausg. v. H. Begemann. Berlin-Göttingen-Heidelberg. Springer 1956, S. 357.Google Scholar
14. Hasler, W.: Der Bluterstammbaum von Ober-Ageri mit einer Ergänzung des Stammbaumes vom Züricher Oberland. Arch. Jul. Klaus-Stift., 32, 1 (1957).Google Scholar
15. Hill, J. M. and Speer, R. J.: Combined hemophilia and PTC-Deficiency. Blood, 10, 357 (1955).CrossRefGoogle ScholarPubMed
16. Huser, H. J., Moor-Jankowski, J. K., Truog, G. und Geiger, M.: Klinische, genetische und gerinnungsphysiologische Aspekte der Haemophilie B bei den Blutern von Tenna, mit einem Beitrag zur Genetik der Gerinnungsfaktoren. Acta genet., 8, 25 (1958).Google Scholar
17. Israel, M. C. G., Lempert, H. and Gilbertson, E.: Haemophilia in the female. Lancet, 260, 673 (1952).Google Scholar
18. Jürgens, R. und Ferlin, A.: Ueber den Prothrombin-Consumptiontest bei Hämophilie und bei konstitutioneller Thrombopathie. Schweiz, med. Wschr., 80, 1098 (1950).Google Scholar
19. Koller, F., Krusi, G. und Luchsinger, P.: Ueber eine besondere Form hämorrhagischer Diathese. Schweiz, med. Wschr., 80, 1101 (1950).Google Scholar
20. Koller, F.: Zur Differenzierung der Hämophilie 13. Jber. Schweiz. Ges. Vererbungsforsch. Arch Jul. Klaus-Stiftung, 28, 254 (1953).Google Scholar
21. Koller, F.: Klinik und Therapie der plasmatisch bedingten hämorrhagischen Diathesen. In: Jürgens, und Deutsch, E., Hämorrhagische Diathesen. Wiener Symposium. Wien: Springer 1955. S. 89.CrossRefGoogle Scholar
22. Koller, F., Bachmann, F. und Zollinger, W.: Ueber den Erbgang des kongenitalen Stuart-ProwerFaktor- und Faktor-VII-Mangels. Kongressbericht der Dtsch. Ges. f. innere Med. Bd. 64 im Druck.Google Scholar
23. Lehmann, W.: Bemerkungen zur Genetik der hämorrhagischen Diathesen. In: Jürgens, R. und Deutsch, E., Hämorrhagische Diathesen. Wiener Symposium. Wien: Springer 1955, S. 114.CrossRefGoogle Scholar
24. Lehmann, W.: Die Genetik der hämorrhagischen Diathesen. V. Kongr. d. Europ. Ges. f. Hämatologie. Herausg. v. H. Begemann, Berlin-Göttingen-Heidelberg. Springer 1956, S. 364.Google Scholar
25. Margolius, A. and Ratnoff, O. D.: Observations on the hereditary nature of Hageman-trait. Blood, 11, 565 (1956).CrossRefGoogle ScholarPubMed
26. Margolius, A. and Ratnoff, O. D.: A Laboratory Study of the Carrier State in Classic Hemophilia. J. clin. Invest., 35, 1316 (1956).CrossRefGoogle ScholarPubMed
27. Marx, R., Bayerle, H. und Jörgens, H.: Zur Methodik der hämatologischen Diagnose der hämophilen Anlageträgerinnen. Dtsch. Arch. klin. Med., 194, 294 (1949).Google Scholar
28. Merskey, C. and Macfarlane, R. C.: The Female Carrier of Hemophilia. Lancet, 260, 487 (1951).CrossRefGoogle Scholar
29. Merskey, C. and MacFarlane, R. G.: The Female Carrier of haemophilia. A clinical and laboratory study. Lancet 1, 487 (1951).CrossRefGoogle ScholarPubMed
30. Moor-Jankowski, J.K., Truog, G. und Huser, H. J.: Der Bluterstamm von Tenna und die Nachkommen. 1650-1955. Acta genet., 7, 597 (1957).Google Scholar
31. Pola, V. und Svojitka, J.: Klassische Hämophilie bei Frauen. Fol. haemat., (Lpz) 75, 43 (1957).Google Scholar
32. Rosenthal, R. L.: Plasma Thromboplastin Antecedent Deficiency. J. clin. Invest., 43, 961 (1954).Google Scholar
33. Rosenthal, R. L., Dreskin, O. H. and Rosenthal, N.: Plasma thromboplastin antecedent (PTA) deficiency: Clinical, therapeutic and hereditary aspects of a new hemophilia-like disease. Blood, 10, 120 (1955).CrossRefGoogle ScholarPubMed
34. Rosin, F., Moor-Jankowski, J. K. und Schneeberger, : Die Fertilität im Bluterstamm von Tenna (Hämophilie B). Acta genet., 8, 1 (1958).Google ScholarPubMed
35. Schloessmann, H.: Die Hämophilie. Stuttgart 1930.Google Scholar
36. Sjölin, K. E.: On demonstration of the haemophilic conductor, especially by determination of the coagulation time. Acta pathol. scand., 35, 512 (1954).CrossRefGoogle ScholarPubMed
37. Sjölin, K. E.: Classical Haemophilia (AHF Deficiency) and Christmas Factor (PTC) deficiency as simultaneous defects. Acta med. scand. 159, 1 (1957).CrossRefGoogle ScholarPubMed
38. Sjölin, K. E.: The Hageman trait in a family with haemorrhagic diathesis. Acta genet., 7, 541 (1957).Google Scholar
39. Sköld, E.: Blood coagulation in conductors of hemophilia. Acta genet, et statist, med. (Basel)., 3, 101 (1952).Google Scholar
40. Soulier, J. P. and Larrieu, M. I.: Differentiation of hemophilia into two groups. A study of thirty-three cases. New England J. Med., 249, 547 (1953).CrossRefGoogle ScholarPubMed
41. Verstraete, M. et Vandenbroucke, J.: Le diagnostic des porteuses du gène hémophilique. Rev. Hémat., 10, 547 (1955).Google Scholar
42. Verstraete, M. et Vandenbroucke, J.: Combined antihemophilic globulin and Christmas factor deficiency in hemophilia. Lancet, 268, 869 (1955).CrossRefGoogle Scholar
43. Vogel, F.: Neue Ergebnisse der Hämophilieforschung. Blut, 1, 214 (1955).CrossRefGoogle Scholar